CDC Says Pfizer-BioNTech, Moderna New Boosters Better Than Older Formulation in COVID-19 Prevention



MT Newswires 2022

All news about PFIZER, INC.

Analyst Recommendations on PFIZER, INC.

Sales 2022 100 B

Net income 2022 33 688 M

Net cash 2022 5 430 M

P/E ratio 2022 8,53x
Yield 2022 3,35%
Capitalization 276 B
276 B
EV / Sales 2022 2,70x
EV / Sales 2023 3,37x
Nbr of Employees 79 000
Free-Float 59,0%



Duration :


Period :




Pfizer, Inc. Technical Analysis Chart | MarketScreener

Technical analysis trends PFIZER, INC.

Short Term Mid-Term Long Term
Trends Bullish Neutral Bearish

Income Statement Evolution

Sell

Buy

Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 48,18 $
Average target price 53,78 $
Spread / Average Target 11,6%




Source link

Ozinize
Logo
Shopping cart